Medical Device Global Market Access Podcast By Pure Global cover art

Medical Device Global Market Access

Medical Device Global Market Access

By: Pure Global
Listen for free

Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2026 Pure Global
Episodes
  • Decentralized Diagnostics: Regulatory Pathways for AI-Powered Imaging in 2026

    Decentralized Diagnostics: Regulatory Pathways for AI-Powered Imaging in 2026
    Mar 29 2026
    This episode explores the transformative potential of AI-enabled imaging and ultrasound tools designed for non-experts, set to reshape diagnostics by 2026. We dissect the four emerging business models—hardware, workflow software (SaMD), remote interpretation, and population-scale screening—and analyze the unique global regulatory, data privacy, and market access challenges associated with each. Discover which strategies are best positioned to succeed in this new era of decentralized healthcare. Key Questions: - How will AI empower non-specialists to use advanced ultrasound and imaging tools by 2026? - What are the four primary business models emerging from this technology shift? - What specific regulatory hurdles exist for AI-enabled hardware versus Software as a Medical Device (SaMD)? - How do data privacy laws like GDPR and HIPAA impact remote interpretation services? - What are the unique market access challenges for population-scale screening programs? - Why is a unified global regulatory strategy essential for success in this new market? - Which business model is best positioned to capture value by navigating these complexities? Navigating the complex regulatory landscape for AI-driven medical devices is critical. Pure Global specializes in helping innovative MedTech and IVD companies commercialize their products globally. We develop efficient regulatory strategies for complex technologies like Software as a Medical Device (SaMD) and AI-enabled hardware, helping you overcome market access hurdles in over 30 countries. Our integrated approach combines local expertise with advanced AI tools to streamline technical dossier submission and ensure ongoing compliance. To accelerate your global expansion, contact Pure Global at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show more Show less
    4 mins
  • The 2026 Surgical Robotics Shake-Up: FDA Approvals, Specialization, and New Competition

    The 2026 Surgical Robotics Shake-Up: FDA Approvals, Specialization, and New Competition
    Mar 28 2026
    This episode explores the transformative shift in the surgical robotics market, predicting a move away from a single-player monopoly by 2026. We analyze the impact of new FDA-approved platforms from giants like Medtronic and Johnson & Johnson, the rise of specialization in fields such as orthopedics and cardiac surgery, and how competition is now being driven by factors like price, workflow efficiency in ambulatory surgical centers, and the integration of artificial intelligence. - Will the surgical robotics market remain dominated by one giant in 2026? - How are new FDA approvals for Medtronic’s Hugo and J&J’s Ottava changing the competitive landscape? - Is specialization in spine, cardiac, and microsurgery the new frontier for robotic platforms? - How do smaller, modular robots create new opportunities in ambulatory surgical centers (ASCs)? - What role does Artificial Intelligence (AI) play in differentiating the next generation of surgical robots? - Are high costs and complex training no longer significant barriers to robotic surgery adoption? - What does increased competition mean for innovation, hospital procurement, and patient care? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI tools. From developing regulatory strategy and compiling technical dossiers to acting as your in-country representative in over 30 markets, we accelerate your path to commercialization. Our AI and data tools offer powerful market research capabilities, helping you identify the best regions for expansion. Whether you are a startup or a multinational, Pure Global provides efficient, technology-driven solutions for your global ambitions. Contact us at info@pureglobal.com, visit https://pureglobal.com/, or explore our FREE AI tools at https://pureglobal.ai/.
    Show more Show less
    3 mins
  • FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026

    FDA's New Cybersecurity Era: Why SBOMs and Secure Architecture are Non-Negotiable for MedTech by 2026
    Mar 27 2026
    This episode examines how U.S. FDA regulations have repositioned cybersecurity as a core feature of medical devices. We discuss the impact of the Consolidated Appropriations Act of 2023 and the FDA's "Refuse to Accept" policy, exploring why a secure architecture, a Software Bill of Materials (SBOM), and robust incident response plans are now critical for regulatory approval, hospital trust, and commercial success heading into 2026. - What new authority did the FDA gain over medical device cybersecurity in 2023? - Why is a Software Bill of Materials (SBOM) now a mandatory part of FDA submissions? - How has "secure by design" shifted from a best practice to a regulatory necessity? - What are the essential components of a compliant post-market cybersecurity plan? - How will a device's security posture directly influence hospital purchasing decisions by 2026? - What is the FDA's "Refuse to Accept" policy for cybersecurity? - How can manufacturers prepare their technical dossiers for these new requirements? Pure Global offers end-to-end consulting for MedTech and IVD companies, helping you navigate complex regulatory landscapes like the FDA's new cybersecurity rules. Our experts develop efficient regulatory strategies and use advanced AI to compile and submit technical dossiers that meet these stringent new standards. We act as your local representative to ensure continuous compliance and monitor regulatory changes that could impact your market access. Let us help you get to market faster. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show more Show less
    3 mins
No reviews yet